{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:09:10Z","timestamp":1759882150238,"version":"build-2065373602"},"reference-count":144,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.rgmx.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T23:54:33Z","timestamp":1591746873000},"page":"332-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Consenso Mexicano de hepatitis alcoh\u00f3lica"],"prefix":"10.1016","volume":"85","author":[{"given":"J.A.","family":"Velarde-Ruiz Velasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Higuera-de la Tijera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.E.","family":"Castro-Narro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zamarripa-Dorsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Abdo-Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Aiza Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Aldana Ledesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Bielsa-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Cerda-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.E.","family":"Cisneros-Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Contreras-Oma\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Reyes-Dorantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.","family":"Fern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.S.","family":"Garc\u00eda-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Icaza-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kershenobich-Stalnikowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Lira-Pedr\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Moreno-Alc\u00e1ntar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"P\u00e9rez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Ramos-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Rizo-Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Solana-Sent\u00edes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Torre-Delgadillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2020.04.002_bib0725","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2105\/AJPH.74.9.979","article-title":"Consensus methods: characteristics and guidelines for use","volume":"74","author":"Fink","year":"1984","journal-title":"Am J Public Health."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0730","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0735","first-page":"417","article-title":"Sistema GRADE para clasificar nivel de evidencia y grado de las recomendaciones para la elaboraci\u00f3n de gu\u00edas de buena pr\u00e1ctica cl\u00ednica","volume":"77","author":"O\u00f1ate-Oca\u00f1a","year":"2009","journal-title":"Cir Ciruj."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0740","unstructured":"World Health Organization. Global status report on alcohol and health 2014. Geneva, Switzerland. 2014 Disponible en: http:\/\/apps.who.int\/iris\/bitstream\/10665\/112736\/1\/9789240692763_eng.pdf"},{"key":"10.1016\/j.rgmx.2020.04.002_bib0745","unstructured":"Secretar\u00eda de Salud, Subsecretar\u00eda de Integraci\u00f3n y Desarrollo del Sector Salud Direcci\u00f3n General de Evaluaci\u00f3n del Desempe\u00f1o. Informe sobre la salud de los mexicanos 2015: Diagn\u00f3stico general de la salud poblacional 2015 Disponible en: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/64176\/INFORME_LA_SALUD_DE_LOS_MEXICANOS_2015_S.pdf"},{"key":"10.1016\/j.rgmx.2020.04.002_bib0750","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"64","author":"Hasin","year":"2007","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0755","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0760","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-017-0082-0","article-title":"Comparison of DSM-IV and DSM-5 criteria for alcohol use disorders in VA primary care patients with frequent heavy drinking enrolled in a trial","volume":"12","author":"Takahashi","year":"2017","journal-title":"Addict Sci Clin Pract."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0765","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision (ICD-10) 2016 Disponible en: https:\/\/icd.who.int\/browse10\/2016\/en#\/F10.1"},{"key":"10.1016\/j.rgmx.2020.04.002_bib0770","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cld.2016.02.004","article-title":"Pathogenesis of Alcoholic Liver Disease","volume":"20","author":"Dunn","year":"2016","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0775","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1530-0277.1991.tb00518.x","article-title":"Alcoholic liver disease: pathologic, pathogenetic and clinical aspects","volume":"15","author":"Ishak","year":"1991","journal-title":"Alcohol Clin Exp Res."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0780","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2008-1040605","article-title":"Histologic spectrum of alcoholic liver disease","volume":"6","author":"MacSween","year":"1986","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0785","doi-asserted-by":"crossref","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","article-title":"Alcoholic Liver Disease: Pathogenesis and Current Management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0790","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bpg.2013.08.001","article-title":"Liver abnormalities in drug and substance abusers","volume":"27","author":"Pateria","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0795","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.22576","article-title":"Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease","volume":"49","author":"Naveau","year":"2009","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0800","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jgh.12030","article-title":"Alcoholic liver disease: pathogenesis, management, and novel targets for therapy","volume":"28","author":"Orman","year":"2013","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0805","first-page":"209","article-title":"The epidemiology of alcoholic liver disease","volume":"27","author":"Mann","year":"2003","journal-title":"Alcohol Res Health."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0810","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3748\/wjg.v20.i9.2143","article-title":"Therapy for alcoholic liver disease","volume":"20","author":"Jaurigue","year":"2014","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0815","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7326\/0003-4819-156-12-201206190-00004","article-title":"Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: A Danish nationwide cohort study","volume":"156","author":"Jepsen","year":"2012","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0820","first-page":"95","article-title":"The treatment of alcohol abuse and alcoholism: psychosocial and pharmacological management","volume":"15","author":"Addolorato","year":"2003","journal-title":"Alcologia Eur J Alcohol Stud."},{"volume":"1","year":"1995","author":"Nowinski","key":"10.1016\/j.rgmx.2020.04.002_bib0825"},{"volume":"2","year":"1994","author":"Miller","key":"10.1016\/j.rgmx.2020.04.002_bib0830"},{"volume":"3","year":"1995","author":"Kadden","key":"10.1016\/j.rgmx.2020.04.002_bib0835"},{"key":"10.1016\/j.rgmx.2020.04.002_bib0840","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15288\/jsa.1997.58.7","article-title":"Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes","volume":"58","author":"Allen","year":"1997","journal-title":"J Stud Alcohol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0845","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cgh.2015.07.047","article-title":"Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review","volume":"14","author":"Khan","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0850","unstructured":"Secretar\u00eda de Salud, Comisi\u00f3n Nacional contra las Adicciones. Programa de acci\u00f3n Espec\u00edfico prevenci\u00f3n y atenci\u00f3n integral de las adicciones 2015. Disponible en: http:\/\/www.conadic.salud.gob.mx\/pdfs\/programas\/PAE_2015.pdf"},{"key":"10.1016\/j.rgmx.2020.04.002_bib0855","unstructured":"World Health Organization. Brief Intervention: For Hazardous and Harmful Drinking: a manual for use in primary care. Thomas F. Babor, John C. Higgins-Biddle 2001. Disponible en: https:\/\/apps.who.int\/iris\/handle\/10665\/67210"},{"key":"10.1016\/j.rgmx.2020.04.002_bib0860","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL Clinical Practice Guidelines: Management of alcohol-related liver disease","volume":"69","author":"Thursz","year":"2018","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0865","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/add.13341","article-title":"Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries","volume":"111","author":"Kalinowski","year":"2016","journal-title":"Addiction."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0870","unstructured":"Norma Oficial Mexicana NOM-142-SSA1\/SCFI-2014, Bebidas alcoh\u00f3licas. Especificaciones sanitarias. Etiquetado sanitario y comercial. Diario Oficial de la Federaci\u00f3n 23-Marzo-2015. 2015 Disponible en: http:\/\/www.dof.gob.mx\/nota_detalle.php%3Fcodigo%3D5386313%26fecha%3D23\/03\/2015"},{"key":"10.1016\/j.rgmx.2020.04.002_bib0875","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1530-0277.1993.tb05673.x","article-title":"Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol","volume":"17","author":"Savolainen","year":"1993","journal-title":"Alcohol Clin Exp Res."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0880","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jhep.2018.10.041","article-title":"Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study","volume":"70","author":"Thursz","year":"2019","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0885","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.41.6.845","article-title":"Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group","volume":"41","author":"Bellentani","year":"1997","journal-title":"Gut."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0890","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.5694\/j.1326-5377.1971.tb50304.x","article-title":"Physical disease in alcoholism. Initial survey of 1.000 patients","volume":"1","author":"Wilkinson","year":"1971","journal-title":"Med J Aust."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0895","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/bmj.282.6270.1140","article-title":"Do women develop alcoholic liver disease more readily than men?","volume":"282","author":"Saunders","year":"1981","journal-title":"Br Med J (Clin Res Ed)."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0900","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrgastro.2018.8","article-title":"Women and alcoholic liver disease - warning of a silent danger","volume":"15","author":"Szabo","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0905","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2014.12.005","article-title":"Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study","volume":"62","author":"Askgaard","year":"2015","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0910","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/alcalc\/37.6.618","article-title":"Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers","volume":"37","author":"Pelletier","year":"2002","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0915","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/hep.29631","article-title":"Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population","volume":"67","author":"\u00c5berg","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0920","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1478-3231.2010.02261.x","article-title":"Interaction of alcohol intake and cofactors on the risk of cirrhosis","volume":"30","author":"Stroffolini","year":"2010","journal-title":"Liver Int."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0925","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/00365521.2013.777469","article-title":"Smoking and risk of liver cirrhosis: a population-based cohort study","volume":"48","author":"Dam","year":"2013","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0930","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0935","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0940","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gut.2009.189639","article-title":"Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study","volume":"59","author":"Katoonizadeh","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.rgmx.2020.04.002_bib0945","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12072-017-9790-5","article-title":"New paradigms in management of alcoholic hepatitis: a review","volume":"11","author":"Sidhu","year":"2017","journal-title":"Hepatol Int."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta191020","article-title":"The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2?\u00d7?2 factorial randomised controlled trial","volume":"19","author":"Thursz","year":"2015","journal-title":"Health Technol Assess."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0955","article-title":"Correction: Survival from alcoholic hepatitis has not improved over time","volume":"13","author":"Hughes","year":"2018","journal-title":"PLoS One."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0960","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/ajg.2011.141","article-title":"The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis","volume":"106","author":"Altamirano","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0965","first-page":"677","article-title":"Malnutrition is a key prognostic factor related to high mortality-rate in patients with severe alcoholic hepatitis","volume":"35","author":"Higuera-de la Tijera","year":"2018","journal-title":"Nutr Hosp."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0970","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG Clinical Guideline: Alcoholic Liver Disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0975","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0980","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/j.1572-0241.2008.01837.x","article-title":"Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function","volume":"103","author":"Lucey","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.alcohol.2017.07.006","article-title":"Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis","volume":"66","author":"Whitfield","year":"2018","journal-title":"Alcohol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0990","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMra1610570","article-title":"Use of Liver Imaging and Biopsy in Clinical Practice","volume":"377","author":"Tapper","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmx.2020.04.002_bib0995","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jmri.22580","article-title":"Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy","volume":"34","author":"Reeder","year":"2011","journal-title":"J Magn Reson Imaging."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1000","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.gastrohep.2014.02.001","article-title":"Alcoholic hepatitis: Prognosis and treatment","volume":"37","author":"Casanova","year":"2014","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1005","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2015.09.040","article-title":"Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis","volume":"150","author":"Thiele","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/apt.13524","article-title":"Systematic review with meta-analysis: diagnostic accuracy of transient elastography for staging of fibrosis in people with alcoholic liver disease","volume":"43","author":"Pavlov","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1020","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.7150\/thno.18650","article-title":"Ultrasound Elastography: Review of Techniques and Clinical Applications","volume":"7","author":"Sigrist","year":"2017","journal-title":"Theranostics."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2214\/AJR.16.16565","article-title":"Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy","volume":"208","author":"Kramer","year":"2017","journal-title":"AJR Am J Roentgenol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1030","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrgastro.2018.10","article-title":"Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD","volume":"15","author":"Tapper","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.acra.2014.01.007","article-title":"Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation","volume":"21","author":"Maruzzelli","year":"2014","journal-title":"Acad Radiol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1045","first-page":"17","article-title":"Accuracy of ultrasonography in evaluation of level and cause of biliary obstruction: a prospective study","volume":"3","author":"Ghimire","year":"2005","journal-title":"Kathmandu Univ Med J (KUMJ)."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4321\/S1130-01082004000100008","article-title":"Diagnostic and therapeutic approach to cholestatic liver disease","volume":"96","author":"P\u00e9rez Fern\u00e1ndez","year":"2004","journal-title":"Rev Esp Enferm Dig."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1055","unstructured":"Mayo Clinic. The Alcoholic Liver Disease\/Nonalcoholic Fatty Liver Disease Index (ANI) 2006. Disponible en: https:\/\/www.mayoclinic.org\/medical-professionals\/transplant-medicine\/calculators\/the-alcoholic-liver-disease-nonalcoholic-fatty-liver-disease-index-ani\/itt-20434726"},{"key":"10.1016\/j.rgmx.2020.04.002_bib1060","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1053\/j.gastro.2006.08.020","article-title":"Utility of a new model to diagnose an alcohol basis for steatohepatitis","volume":"131","author":"Dunn","year":"2006","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0140-6736(82)91579-3","article-title":"Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism","volume":"1","author":"Bernadt","year":"1982","journal-title":"Lancet."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1070","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1360-0443.1995.tb02810.x","article-title":"Predictive capacity of the AUDIT questionnaire for alcohol-related harm","volume":"90","author":"Conigrave","year":"1995","journal-title":"Addiction."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/occmed\/kqu058","article-title":"The CAGE questionnaire","volume":"64","author":"Williams","year":"2014","journal-title":"Occup Med (Lond)."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/occmed\/kqu011","article-title":"The AUDIT questionnaire","volume":"64","author":"Williams","year":"2014","journal-title":"Occup Med (Lond)."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1085","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/0148607195019004258","author":"Mendenhall","year":"1995","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","article-title":"ESPEN guideline on clinical nutrition in liver disease","volume":"38","author":"Plauth","year":"2019","journal-title":"Clin Nutr."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1100","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1105","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/acer.12422","article-title":"Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder","volume":"38","author":"Glass","year":"2014","journal-title":"Alcohol Clin Exp Res."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/gut.2008.162453","article-title":"Cigarette smoking and chronic liver diseases","volume":"59","author":"Altamirano","year":"2010","journal-title":"Gut."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/19371918.2013.758960","article-title":"The many roles of social workers in the prevention and treatment of alcohol and drug addiction: a major health and social problem affecting individuals, families, and society. Introduction","volume":"28","author":"Daley","year":"2013","journal-title":"Soc Work Public Health."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1125","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1140","first-page":"306","article-title":"The amount of alcohol intake, upper gastrointestinal bleeding, acute renal failure and hepatic encephalopathy as the risk factors implied in the increase of patients with alcoholic hepatitis","volume":"74","author":"Higuera-de la Tijera","year":"2009","journal-title":"Rev Gastroenterol Mex."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1145","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"1","author":"Carithers","year":"1989","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1155","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cld.2016.02.007","article-title":"Prognosis and prognostic scoring models for alcoholic liver disease and acute alcoholic hepatitis","volume":"20","author":"Gholam","year":"2016","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2017.11.017","article-title":"Application of prognostic scores in the STOPAH trial: discriminant function is no longer the optimal scoring system in alcoholic hepatitis","volume":"68","author":"Forrest","year":"2018","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1165","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1180","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MOG.0000000000000359","article-title":"Alcoholic hepatitis: current trends in management","volume":"33","author":"Aday","year":"2017","journal-title":"Curr Opin Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1190","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1195","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2016.04.029","article-title":"Treatment of alcohol use disorders in patients with alcoholic liver disease","volume":"65","author":"Addolorato","year":"2016","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jhep.2018.12.003","article-title":"Fibrosis and alcohol-related liver disease","volume":"70","author":"Lackner","year":"2019","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11901-017-0343-0","article-title":"Alcohol consumption in concomitant liver disease: how much is too much?","volume":"16","author":"Hagstr\u00f6m","year":"2017","journal-title":"Curr Hepatol Rep."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5604\/16652681.1226814","article-title":"Management strategies for liver fibrosis","volume":"16","author":"Altamirano-Barrera","year":"2017","journal-title":"Ann Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1215","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2018.05.012","article-title":"Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis","volume":"69","author":"Peeraphatdit","year":"2018","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1225","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2018.10.026","article-title":"Current trials and novel therapeutic targets for alcoholic hepatitis","volume":"70","author":"Singal","year":"2019","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1230","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/jhep.2001.27445","article-title":"Complementary and alternative medicine in chronic liver disease","volume":"34","author":"Seeff","year":"2001","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1235","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","article-title":"Hepatoprotective effect of silymarin","volume":"6","author":"Vargas-Mendoza","year":"2014","journal-title":"World J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1240","first-page":"CD003620","article-title":"Milk thistle for alcoholic and\/or hepatitis B or C virus liver disease","volume":"4","author":"Rambaldi","year":"2007","journal-title":"Chochrane Database Syst Rev."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1245","first-page":"1","article-title":"Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects","author":"Mulrow","year":"2000","journal-title":"Evid Rep Technol Assess (Summ)."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1250","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1756283X10378925","article-title":"Treatment of alcoholic liver disease","volume":"4","author":"Frazier","year":"2011","journal-title":"Therap Adv Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1255","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cgh.2016.08.047","article-title":"Medical management of severe alcoholic hepatitis: expert review from the clinical practice updates committee of the AGA institute","volume":"15","author":"Mitchell","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1260","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1053\/j.gastro.2016.02.074","article-title":"Treatment of severe alcoholic hepatitis","volume":"150","author":"Thursz","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1265","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/liv.12798","article-title":"Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis","volume":"35","author":"Fialla","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1270","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabr\u00e9","year":"2000","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1275","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cld.2012.08.009","article-title":"Nutrition in alcoholic liver disease","volume":"16","author":"Singal","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.rgmx.2020.04.002_bib1280","first-page":"227","article-title":"Pentoxifylline versus steroid in short-term survival in severe acute alcoholic hepatitis","volume":"28","author":"Garrido Garc\u00eda","year":"2012","journal-title":"Med Int Mex."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1285","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1290","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/MCG.0000000000000585","article-title":"Corticosteroids versus Pentoxifylline for severe alcoholic hepatitis: a sequential analysis of randomized controlled trials","volume":"50","author":"Njei","year":"2016","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1295","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3748\/wjg.v23.i11.2052","article-title":"Infection does not increase long-term mortality in patients with acute severe alcoholic hepatitis treated with corticosteroids","volume":"23","author":"Dhanda","year":"2017","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cld.2018.09.005","article-title":"Acute Alcoholic Hepatitis","volume":"23","author":"Im","year":"2019","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1305","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1310","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/cld.792","article-title":"New Prospects for Medical Management of Acute Alcoholic Hepatitis","volume":"13","author":"Liu","year":"2019","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1315","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1320","first-page":"CD007339","article-title":"Pentoxifylline for alcoholic hepatitis","author":"Whitfield","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1325","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1330","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MCG.0000000000000674","article-title":"Treatment of severe alcoholic hepatitis with corticosteroid, pentoxifylline, or dual therapy: a systematic review and meta-analysis","volume":"51","author":"Lee","year":"2017","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1335","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/liv.12939","article-title":"Corticosteroids and ocurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials","volume":"36","author":"Hmoud","year":"2016","journal-title":"Liver Int."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1340","first-page":"152","article-title":"Infections in severe alcoholic hepatitis","volume":"30","author":"Karakike","year":"2017","journal-title":"Ann Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1345","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/j.gastro.2004.09.089","article-title":"Anti-TNF therapy for severe acute alcoholic hepatitis: What went wrong?","volume":"127","author":"Blendis","year":"2004","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1350","first-page":"e5082","article-title":"Safety and efficacy of infliximab in severe alcoholic hepatitis: a systematic review","volume":"11","author":"Majeed","year":"2019","journal-title":"Cureus."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1355","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/HMER.S197933","article-title":"Severe alcoholic hepatitis: current perspectives","volume":"11","author":"Philips","year":"2019","journal-title":"Hepat Med."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1360","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/03007995.2018.1479247","article-title":"Advances in the treatment of severe alcoholic hepatitis","volume":"35","author":"Wang","year":"2019","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1365","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1370","doi-asserted-by":"crossref","first-page":"C29","DOI":"10.12968\/hmed.2014.75.Sup2.C29","article-title":"The clinical use of granulocyte-colony stimulating factor","volume":"75","author":"Shah","year":"2014","journal-title":"Br J Hosp Med (Lond)."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1375","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1380","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.dld.2007.08.006","article-title":"Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure","volume":"39","author":"Di Campli","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.rgmx.2020.04.002_bib1385","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1390","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s13063-018-3092-7","article-title":"Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial","volume":"19","author":"Cho","year":"2018","journal-title":"Trials."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1395","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1574887113666180227100217","article-title":"Pharmacology, Systematic Review and Recent Clinical Trials of Metadoxine","volume":"13","author":"Di Miceli","year":"2018","journal-title":"Rev Recent Clin Trials."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1400","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/phrs.2001.0883","article-title":"Metadoxine prevents damage produced by ethanol and acetaldehyde in hepatocyte and hepatic stellate cells in culture","volume":"44","author":"Guti\u00e9rrez-Ruiz","year":"2001","journal-title":"Pharmacol Res."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1405","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1665-2681(19)30863-4","article-title":"Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis","volume":"13","author":"Higuera-de la Tijera","year":"2014","journal-title":"Ann Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1410","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.3748\/wjg.v21.i16.4975","article-title":"Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis","volume":"21","author":"Higuera-de la Tijera","year":"2015","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1415","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2018.11.007","article-title":"Liver transplantation for alcoholic hepatitis","volume":"70","author":"Im","year":"2019","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1420","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3748\/wjg.v24.i26.2785","article-title":"Liver transplantation and alcoholic liver disease: history, controversies, and considerations","volume":"24","author":"Marroni","year":"2018","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1425","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00423-018-1720-z","article-title":"Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis","volume":"403","author":"Al-Saeedi","year":"2018","journal-title":"Langenbecks Arch Surg."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1430","doi-asserted-by":"crossref","first-page":"e0190823","DOI":"10.1371\/journal.pone.0190823","article-title":"Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis","volume":"13","author":"Marot","year":"2018","journal-title":"PLoS One."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1435","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.04.002_bib1440","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.3748\/wjg.v20.i25.8011","article-title":"Extracorporeal liver support in severe alcoholic hepatitis","volume":"20","author":"Par\u00e9s","year":"2014","journal-title":"World J Gastroenterol."}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090620300483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090620300483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:47:48Z","timestamp":1759812468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090620300483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0375090620300483"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2020.04.002","relation":{},"ISSN":["0375-0906"],"issn-type":[{"type":"print","value":"0375-0906"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consenso Mexicano de hepatitis alcoh\u00f3lica","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}